DNA repair in normal and cancer stem cells, with special reference to the central nervous system

Current Medicinal Chemistry

Volumn 16, Issue 7, 2009, Pages 854-866

  Frosina, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cancer; CD133; Differentiation; DNA repair; Stem cells

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; BONE MORPHOGENETIC PROTEIN; CANNABIS DERIVATIVE; CARMUSTINE; CD133 ANTIGEN; MICRORNA; NERVE CELL ADHESION MOLECULE L1; ONCOLYTIC ADENOVIRUS; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER STEM CELL; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DNA ALKYLATION; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; GENE MUTATION; GLIOMA; GLIOMA CELL; HEMATOPOIETIC STEM CELL; HUMAN; IRRADIATION; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DNA REPAIR; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 65649105812     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787549253     Document Type: Review

References (187)

1. Zeng, X.; Rao, M.S. Human embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience, 2007, 145, 1348-1358
2. Efroni, S.; Duttagupta, R.; Cheng, J.; Dehghani, H.; Hoeppner, D.J.; Dash, C.; Bazett-Jones, D.P.; Le Grice, S.; McKay, R.D.; Buetow, K.H.; Gingeras, T.R.; Misteli, T.; Meshorer E. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell, 2008, 2, 437-447.
3. Hong, Y.; Cervantes, R.B.; Tichy, E.; Tischfield, J.A.; Stambrook, P.J. Protecting genomic integrity in somatic cells and embryonic stem cells. Mutat. Res., 2007, 614, 48-55.
4. Kenyon, J.; Gerson, S.L. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2008, 35, 7557-7565.
5. Vescovi, A.L.; Galli, R.; Reynolds, B.A. Brain tumour stem cells. Nat. Rev. Cancer, 2006, 6, 425-436.
6. Stambrook, P.J. An ageing question: Do embryonic stem cells protect their genomes? Mech. Ageing Dev., 2007, 128, 31-35.
7. de Waard, H.; Sonneveld, E.; de Wit, J.; Lange, R.E.; Hoeijmakers, J.H.; Vrieling, H.; van der Horst, G.T. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts. DNA Repair, 2008, 7, 1659-1669.
8. Rachidi, W.; Harfourche, G.; Lemaitre, G.; Amiot, F.; Vaigot, P.; Martin, M.T. Sensing radiosensitivity of human epidermal stem cells. Radiother. Oncol., 2007, 83, 267-276.
9. Chambers, S.M.; Shaw, C.A.; Gatza, C.; Fisk, C.J.; Donehower, L.A.; Goodell, M.A. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol., 2007, 5, e201.
10. Rando, T.A. The immortal strand hypothesis: Segregation and reconstruction. Cell, 2007, 129, 1239-1243.
11. Potten, C.S.; Owen, G.; Booth, D. Intestinal stem cells protect their genome by selective segregation of template DNA strans. J. Cell Sci., 2002, 115, 2381-2388.
12. Smith, G.H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template strands. Development, 2005, 132, 681-687.
13. Karpowicz, P.; Morshead, C.; Kam, A.; Jervis, E.; Ramunas, J.; Cheng, V.; van der Kooy, D. Support for the immortal strand hypothesis: Neural stem cells partition DNA strands asymetrically in vitro. J. Cell Biol. 2005, 170, 721-732. Erratum in: J. Cell Biol., 2005, 170, 1169.
14. Shinin, V.; Gayraud-Morel, B.; Gomes, D.; Tajbakhsh, S. Asymetric division and cosegregation of template DNA strands in adult mucle satellite cells. Nat. Cell Biol., 2006, 8, 677-687.
15. Cairns, J. Cancer and the immortal strand hypothesis. Genetics, 2006, 174, 1069-1072.
16. Lansdorp, P.M. Immortal strands? Give me a break. Cell, 2007, 129, 1244-1247.
17. Waghmare, S.K.; Bansal, R.; Lee, J.; Zhang, Y.V.; McDermitt, D.J.; Tumbar, T. Quantitative proliferation dynamics and random chromosome segregation of hair follicle stem cells. EMBO J., 2008, 27, 1309-1320.
18. Prall, W.C.; Czibere, A.; Jager, M.; Spentzos, D.; Libermann, T.A.; Gattermann, N.; Haas, R.; Aivado, M. Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cells. Mech. Ageing Dev., 2007, 128, 503-510.
19. Park, Y.; Gerson, S.L. DNA repair defects in stem cell function and aging. Annu. Rev. Med., 2005, 56, 495-508.
20. Lin, Q.; Donahue, S.L.; Ruley, H.E. Genome maintenance and mutagenesis in embryonic stem cells. Cell Cycle, 2006, 5, 2710-2714.
21. Donahue, S.L.; Lin, Q.; Cao, S.; Ruley, H.E. Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc. Natl. Acad. Sci. USA, 2007, 103, 11642-11646.
22. Gotherstrom, C.; West, A.; Liden, J.; Uzunel, M.; Lahesmaa, R.; Le Blanc, K. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica, 2005, 90, 1017-1026.
23. Tichy, E.D.; Stambrook, P.J. DNA repair in murine embryonic stem cells and differentiated cells. Exp. Cell Res., 2008, 314, 1929-1936.
24. Weinstock, D.M.; Jasin, M. Alternative pathways for the repair of RAG-induced DNA breaks. Mol. Cell Biol., 2006, 26, 131-139.
25. Saretzki, G.; Armstrong, L.; Leake, A.; Lako, M.; von Zglinicki, T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells, 2004, 22, 962-971.
26. Saretzki, G.; Walter, T.; Atkinson, S.; Passos, J.F.; Bareth, B.; Keith, W.N.; Stewart, R.; Hoare, S.; Stojkovic, M.; Armstrong, L.; von Zglinicki, T.; Lako, M. Down-regulation of multiple stress defence mechanisms during differentiation of human embryonic stem cells. Stem Cells, 2008, 26, 455-464.
27. Bracker, T.U.; Giebel, B.; Spanholtz, J.; Sorg, U.R.; Klein-Hitpass, L.; Moritz, T.; Thomale, J. Stringent regulation of DNA repair during human hematopietic differentiation: A gene expression and functional analysis. Stem Cells, 2006, 24, 722-730.
28. Chen, M.F.; Lin, C.T.; Chen, W.C.; Yang, C.T.; Chen, C.C.; Liao, S.K.; Liu, J.M.; Lu, C.H.; Lee, K.D. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys., 2006, 66, 244-253.
29. Rossi, D.J.; Bryder, D.; Seita, J.; Nussenzweig, A.; Hoeijmakers, J.; Weissman, I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature, 2007, 447, 725-729.
30. Nijnik, A.; Woodbine, L.; Marchetti, C.; Dawson, S.; Lambe, T.; Liu, C.; Rodrigues, N.P.; Crockford, T.L.; Cabuy, E.; Vindigni, A.; Enver, T.; Bell, J.I.; Slijepcevic, P.; Goodnow, C.C.; Jeggo, P.A.; Cornall, RJ. DNA repair is limiting for haematopoietic stem cells during ageing. Nature, 2007, 447, 686-690.
31. Warren, L.A.; Rossi, D.J. Stem cells and aging in the hematopoietic system. Mech. Ageing Dev., 2008, in press.
32. Nowak, E.; Etienne, O.; Millet, P.; Lages, C.S.; Mathieu, C.; Mouthon, M.A.; Boussin, F.D. Radiation-induced H2AX phosphorylation and neural precursor apoptosis in the developing brain of mice. Radiat. Res., 2006, 165, 155-164.
33. Panagiotakos, G.; Alshamy, G.; Chan, B.; Abrams, R.; Greenberg, E.; Saxena, A.; Bradbury, M.; Edgar, M.; Gutin, P.; Tabar, V. Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS ONE, 2007, 2, e588.
34. Serakinci, N.; Christensen, R.; Graakjaer, J.; Cairney, C.J.; Keith, W.N, Alsner, J.; Saretzki, G.; Kolvraa, S. Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart. Exp. Cell Res., 2007, 313, 1056-1067.
35. Hildrestrand, G.A.; Diep, D.B.; Kunke, D.; Bolstad, N.; Bjoras, M.; Krauss, S.; Luna, L. The capacity to remove 8-oxoG is enhanced in newborn neural stem/progenitor cells and decreases in juvenile mice and upon cell differentiation. DNA Repair, 2007, 6, 723-732.
36. Rolseth, V.; Rundén-Pran, E.; Luna, L.; McMurray, C.; Bjørås, M.; Ottersen, O.P. Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair, 2008, 7, 1578-1588.
37. Narciso, L.; Fortini, P.; Pajalunga, D.; Franchitto, A.; Liu, P.; Degan, P.; Frechet, M.; Demple, B.; Crescenzi, M.; Dogliotti, E. Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury. Proc. Natl. Acad. Sci. USA, 2007, 104, 17010-17015.
38. Liang, L.; Deng, L.; Mendonca, M.S.; Chen, Y.; Zheng, B.; Stambrook, P.J.; Shao, C.; Tischfield, J.A. X-rays induce distinct patterns of somatic mutation in fetal versus adult hematopoietic cells. DNA Repair, 2007, 6, 1380-1385.
39. Srivastava, D.K.; Berg, B.J.; Prasad, R.; Molina, J.T.; Beard, W.A.; Tomkinson, A.E.; Wilson, S.H. Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J. Biol. Chem., 1998, 273, 21203-21209.
40. Cappelli, E.; Hazra, T.; Hill, J.W.; Slupphaug, G.; Bugliolo, M.; Frosina, G. Rates of base excision repair are not solely dependent on levels of initiating enzymes. Carcinogenesis, 2001, 22, 387-393.
41. Visnes, T.; Akbari, M.; Hagen, L.; Slupphaug, G.; Krokan, H.E. The rate of base excision repair of uracil is controlled by the initiating glycosylase. DNA Repair, 2008, 7, 1869-1881.
42. Hanawalt, P.C.; Spivak, G. Transcription-coupled DNA repair: Two decades of progress and surprises. Nat. Rev. Mol. Cell Biol., 2008, 9, 958-970.
43. Nouspikel, T.; Hanawalt, P.C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell Biol., 2000, 20, 1562-1570.
44. Nouspikel, T. DNA repair in differentiated cells: Some new answers to old questions. Neuroscience, 2007, 145, 1213-1221
45. Hsu, P.H.; Hanawalt, P.C.; Nouspikel, T. Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation. Mutat. Res., 2007, 614, 3-15
46. Nouspikel, T.P.; Hyka-Nouspikel, N.; Hanawalt, P.C. Transcription domain-associated repair in human cells. Mol. Cell Biol., 2006, 26, 8722-8730.
47. Van der Wees, C.; Jansen, J.; Vrieling, H.; van der Laarse, A.; van Zeeland, A.; Mullenders, L. Nucleotide excision repair in differentiated cells. Mutat. Res., 2007, 614, 16-23.
48. Backendorf, C.; de Wit, J.; van Oosten, M.; Stout, G.J.; Mitchell, J.R.; Borgstein, A.M.; van der Horst, G.T.; de Gruijl, F.R.; Brouwer, J.; Mullenders, L.H.; Hoeijmakers, J.H. Repair characteristics and differentiation propensity of long-term cultures of epidermal keratinocytes derived from normal and NER-deficient mice. DNA Repair, 2005, 4, 1325-1336.
49. Roos, W.P.; Christmann, M.; Fraser, S.T.; Kaina, B. Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high e2F1 regulated mismatch repair. Cell Death Differ., 2007, 14, 1422-1432.
50. Casorelli, I.; Russo, M.T.; Bignami, M. Role of mismatch repair and MGMT in response to anticancer therapies. Anticancer Agents Med. Chem., 2008, 8, 368-380.
51. Casorelli, I.; Pelosi, E.; Biffoni, M.; Cerio, A.M.; Peschle, C.; Testa, U.; Bignami, M. Methylation damage response in hematopoietic progenitor cells. DNA Repair, 2007, 6, 1170-1178.
52. Sii-Felice, K.; Etienne, O.; Hoffschir, F.; Mathieu, C.; Riou, L.; Barroca, V.; Haton, C.; Arwert, F.; Fouchet, P.; Boussin, F.D.; Mouthon, M.A. Fanconi DNA repair pathway is required for survival and long-term maintenance of neural progenitors. EMBO J., 2008, 27, 770-781.
53. Sii-Felice, K.; Barroca, V.; Etienne, O.; Riou, L.; Hoffschir, F, Fouchet, P.; Boussin, F.D.; Mouthon, M.A. Role of fanconi DNA repair pathway in neural stem cell homeostasis. Cell Cycle, 2008, 7, 1911-1915.
54. Madhavan, L.; Ourednik, V.; Ourednik, J. Increased "vigilance" of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress. Stem Cells, 2006, 24, 2110-2119.
55. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
56. Cho, R.W.; Clarke, M.F. Recent advances in cancer stem cells. Curr. Opin. Genet. Dev., 2008, 18, 48-53.
57. Gal, H.; Amariglio, N.; Trakhtenbrot, L.; Jacob-Hirsh, J.; Margalit, O.; Avigdor, A.; Nagler, A.; Tavor, S.; Ein-Dor, L.; Lapidot, T.; Domany, E.; Rechavi, G.; Givol, D. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia, 2006, 20, 2147-2154.
58. Ben-Porath, I.; Thomson, M.W.; Carey, V.J.; Ge, R.; Bell, G.W.; Regev, A.; Weinberg, R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet., 2008, 40, 499-507.
59. Yang, Y.M.; Chang, J.W. Current status and issues in cancer stem cell study. Cancer. Invest., 2008, 5, 1-15.
60. Rubio, D.; Garcia-Castro, J.; Martin, M.C.; de la Fuente, R.; Cigudosa, J.C.; Lloyd, A.C.; Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res., 2005, 65, 3035-3039
61. Siebzehnrubl, F.A.; Jeske, I.; Müller, D.; Buslei, R.; Coras, R.; Hahnen, E.; Huttner, H.B.; Corbeil, D.; Kaesbauer, J.; Appl, T.; von Hörsten, S.; Blümcke, I. Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells. Brain Pathol., 2008, in press.
62. Okamoto, O.K.; Carvalho, A.C.; Marti, L.C.; Vencio, R.Z.; Moreira- Filho, C.A. Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer. Cancer Cell Int., 2007, 7, 11.
63. Gerson, S.L.; Reese, J.; Kenyon, J. DNA repair in stem cell maintenance and conversion to cancer stem cells. Ernst Schering Found. Symp. Proc., 2006, 5, 231-244.
64. Ho, M.M.; Ng, A.V.; Lam, S.; Hung, J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res., 2007, 67, 4827-4833.
65. Beier, D.; Wischhusen, J.; Dietmaier, W.; Hau, P.; Proescholdt, M.; Brawanski, A.; Bogdahn, U.; Beier, C.P. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol., 2008, 18, 370-377.
66. Christensen, K.; Schrøder, H.D.; Kristensen B.W. CD133 identifies perivascular niches in grade II-IV astrocytomas. J. Neurooncol., 2008, 90, 157-170.
67. Rebetz, J.; Tian, D.; Persson, A.; Widegren, B.; Salford, L.G.; Englund, E.; Gisselsson, D.; Fan, X. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS ONE, 2008, 3, e1936.
68. Zeppernick, F.; Ahmadi, R.; Campos, B.; Dictus, C.; Helmke, B.M.; Becker, N.; Lichter, P.; Unterberg, A.; Radlwimmer, B.; Herold-Mende, C.C. Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients. Clin. Cancer Res., 2008, 14, 123-129.
69. Thon, N.; Damianoff, K.; Hegermann, J.; Grau, S.; Krebs, B.; Schnell, O.; Tonn, J.C.; Goldbrunner, R. Presence of pluripotent CD133(+) cells correlates with malignancy of gliomas. Mol. Cell Neurosci., 2008, in press.
70. Sales, K.M.; Winslet, M.C.; Seifalian, A.M. Stem cells and cancer: An overview. Stem Cell Rev., 2007, 3, 249-255.
71. Ailles, L.E.; Weissman, I.L. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol., 2007, 18, 460-466.
72. Ward, R.J.; Dirks, P.B. Cancer stem cells: At the headwaters of tumor development. Annu. Rev. Pathol., 2007, 2, 175-189.
73. Eyler, C.E.; Rich, J.N. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol., 2008, 26, 2839-2845.
74. Schaich, M.; Kestel, L.; Pfirrmann, M.; Robel, K.; Illmer, T.; Kramer, M.; Dill, C.; Ehninger, G.; Schackert, G.; Krex, D. A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. Ann. Oncol., 2008, in press.
75. Trumpp, A.; Wiestler, O.D. Mechanisms of Disease: Cancer stem cells-targeting the evil twin. Nat. Clin. Pract. Oncol., 2008, 5, 337-347.
76. Donnenberg, V.S.; Donnenberg, A.D. Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis. J. Clin. Pharmacol., 2005, 45, 872-877.
77. Lou, H.; Dean, M. Targeted therapy for cancer stem cells: The patched pathway and ABC transporters. Oncogene, 2007, 26, 1357-1360.
78. Dirks, P.B. Brain tumor stem cells: Bringing order to the chaos of brain cancer. J. Clin. Oncol., 2008, 26, 2916-2924.
79. Regenbrecht, C.R.; Lehrach, H.; Adjaye, J. Stemming cancer: Functional genomics of cancer stem cells in solid tumors. Stem Cell Rev., 2008, 4, 319-328.
80. Zhou, J.; Zhang, Y. Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle, 2008, 7, 1360-1370.
81. Sakariassen, P.Ø.; Immervoll, H.; Chekenya, M. Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies. Neoplasia, 2007, 9, 882-892.
82. Yoo, M.H.; Hatfield, D.L. The Cancer Stem Cell Theory: Is It Correct? Mol. Cells, 2008, 26, in press.
83. Kelly, P.N.; Dakic, A.; Adams, J.M.; Nutt, S.L.; Strasser, A. Tumor growth need not be driven by rare cancer stem cells. Science, 2007, 317, 337.
84. Adams, J.M.; Strasser, A. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res., 2008, 68, 4018-4021.
85. Shmelkov, S.V.; Butler, J.M.; Hooper, A.T.; Hormigo, A.; Kushner, J.; Milde, T.; St Clair, R.; Baljevic, M.; White, I.; Jin, D.K.; Chadburn, A.; Murphy, A.J.; Valenzuela, D.M.; Gale, N.W.; Thurston, G.; Yancopoulos, G.D.; D'Angelica, M.; Kemen, N.; Lyden, D.; Rafii, S. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J. Clin. Invest., 2008, 118, 2111-2120.
86. Kennedy, J.A.; Barabe, F.; Poeppl, A.G, Wang, J.C.; Dick, J.E. Comment on "Tumor growth need not be driven by rare cancer stem cells". Science, 2007, 318, 1722.
87. Werbowetski-Ogilvie, T.E.; Bhatia, M. Pluripotent human stem cell lines: what we can learn about cancer initiation. Trends Mol. Med., 2008, 14, 323-332.
88. Hambardzumyan, D.; Squatrito, M.; Carbajal, E.; Holland, E.C. Cancer Stem Cells, and Akt Signaling. Stem Cell Rev., 2008, 4, 203-210.
89. Stiles, C.D.; Rowitch, D.H. Glioma stem cells: A midterm exam. Neuron, 2008, 58, 832-846.
90. Wu, X.Z. Origin of Cancer Stem Cells: The Role of Self-Renewal and Differentiation. Ann. Surg. Oncol., 2008, 15, 407-414.
91. Kern, S.E.; Shibata, D. The fuzzy math of solid tumor stem cells: A perspective. Cancer Res., 2007, 67, 8985-8988.
92. Hill, R.P.; Perris, R. "Destemming" Cancer Stem Cells. J. Natl. Cancer Inst., 2007, 99, 1435-1440.
93. Weiner, L.P. Definitions and criteria for stem cells. Methods Mol. Biol., 2008, 438, 3-8.
94. Ropolo, M.; Daga, A.; Griffero, F.; Foresta, M.; Casartelli, G.; Zunino, A.; Poggi, A.; Cappelli, E.; Zona, G.; Spaziante, R.; Corte, G.; Frosina, G. A comparative analysis of DNA repair in stem and non-stem glioma cell cultures, Mol. Cancer Res., 2009, in press.
95. Qiu, J.; Ai L.; Ramachandran, C.; Yao, B.; Gopalakrishnan, S.; Fields, C.R.; Delmas, A.L.; Dyer, L.M.; Melnick, S.J.; Yachnis, A.T.; Schwartz, P.H.; Fine, H.A.; Brown, K.D.; Robertson, K.D. Invasion suppressor cystatin E/M (CST6): High-level cell typespecific expression in normal brain and epigenetic silencing in gliomas. Lab. Invest., 2008, 88, 910-925.
96. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer, 2005, 5, 275-284.
97. Baumann, M.; Krause, M.; Hill, R. Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer, 2008, 8, 545-554.
98. Lu, C.; Shervington, A. Chemoresistance in gliomas. Mol. Cell Biochem., 2008, 312, 71-80.
99. Shervington, A.; Lu, C. Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest., 2008, 26, 535-542.
100. Torres-Montaner, A.; Hughes, D. A hypothetical anti-neoplastic mechanism associated to reserve cells. J. Theor. Biol., 2004, 231, 239-248.
101. Martinez, R.; Setien, F.; Voelter, C.; Casado, S.; Quesada, M.P.; Schackert, G.; Esteller, M. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis, 2007, 28, 1264-1268.
102. Johannessen, T.C.; Bjerkvig, R.; Tysnes, B.B. DNA repair and cancer stem-like cells - Potential partners in glioma drug resistance? Cancer Treat. Rev., 2008, 34, 558-567.
103. Roth, R.B.; Samson, L.D. 3-methyladenine DNA glycosylase-deficient Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res., 2002, 62, 656-660.
104. Vaish, M. Mismatch repair deficiencies in transforming stem cells into cancer stem cells and therapeutic implications. Mol. Cancer, 2007, 6, 26.
105. Worrillow, L.J.; Allan, J.M. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: A possible role in the aetiology of chemotherapy-induced leukaemia. Oncogene, 2006, 25, 1709-1720.
106. Barami, K. Biology of the subventricular zone in relation to gliomagenesis. J. Clin. Neurosci., 2007, 14, 1143-1149.
107. Xie, Z.; Chin, L.S. Molecular and cell biology of brain tumor stem cells: Lessons from neural progenitor/stem cells. Neurosurg. Focus, 2008, 24, E25.
108. Das, S.; Srikanth, M.; Kessler, J.A. Cancer stem cells and glioma. Nat. Clin. Pract. Neurol., 2008, 4, 427-435.
109. Ma, Y.H.; Mentlein, R.; Knerlich, F.; Kruse, M.L.; Mehdorn, H.M.; Held-Feindt, J. Expression of stem cell markers in human astrocytomas of different WHO grades. J. Neurooncol., 2008, 86, 31-45.
110. Colleoni, F.; Torrente, Y. The new challenge of stem cell: Brain tumour therapy. Cancer Lett., 2008, in press.
111. Strojnik, T.; Rosland, G.V.; Sakariassen, P.O.; Kavalar, R.; Lah, T. Neural stem cell markers, nestin, and musashi proteins in the progression of human glioma: Correlation of nestin with prognosis of patient survival. Surg. Neurol., 2007, 68, 133-143.
112. Maderna, E.; Salmaggi, A.; Calatozzolo, C.; Limido, L.; Pollo, B. Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: Different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information. Cancer Biol. Ther., 2007, 6, [Epub ahead of print].
113. Kong, D.S.; Kim, M.H.; Park, W.Y.; Suh, Y.L.; Lee, J.I.; Park, K.; Kim, J.H.; Nam, D.H. The progression of gliomas is associated with cancer stem cell phenotype. Oncol. Rep., 2008, 19, 639-643.
114. Fan, X.; Salford, L.G.; Widegren, B. Glioma stem cells: Evidence and limitation. Semin. Cancer Biol., 2007, 17, 214-218.
115. Dietrich, J.; Imitola, J.; Kesari, S. Mechanisms of Disease: The role of stem cells in the biology and treatment of gliomas. Nat. Clin. Pract. Oncol., 2008, 5, 393-404.
116. Tabatabai, G.; Bahr, O.; Mohle, R.; Eyupoglu, I.Y.; Beohmler, A.M.; Wischusen, J.; Rieger, J.; Blumcke, I.; Weller, M.; Wick, W. Lessons from bone marrow: How malignant glioma cells attract adult haematopoietic progenitor cells. Brain, 2005, 128, 2200-2211.
117. Serfozo, P.; Schlarman, M.S.; Pierret, C.; Maria, B.L.; Kirk, M.D. Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines. Cancer Cell Int., 2006, 6, 1.
118. Gutova, M.; Najbauer, J.; Frank, R.T.; Kendall, S.E.; Gevorgyan, A.; Metz, M.Z.; Guevorkian, M.; Edmiston, M.; Zhao, D.; Glackin, C.A.; Kim, S.U.; Aboody, K.S. uPA and uPAR Mediate Human Stem Cell Tropism to Malignant Solid Tumors. Stem Cells, 2008, 26, 1406-1413.
119. Jeon, J.Y.; An, J.H.; Kim, S.U.; Park, H.G.; Lee, M.A. Migration of human neural stem cells toward an intracranial glioma. Exp. Mol. Med., 2008, 40, 84-91.
120. Jurvansuu, J.; Zhao, Y.; Leung, D.S.; Boulaire, J.; Yu, Y.H.; Ahmed, S.; Wang, S. Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Cancer Res., 2008, 68, 4614-4622.
121. Kendall, S.E.; Najbauer, J.; Johnston, H.F.; Metz, M.Z.; Li, S.; Bowers, M.; Garcia, E.; Kim, S.U.; Barish, M.E.; Aboody, K.S.; Glackin, C.A. Neural Stem Cell Targeting of Glioma is Dependent on PI3K Signaling. Stem Cells, 2008, 26, 1575-1586.
122. Xu, F.; Zhu, J.H. Stem cells tropism for malignant gliomas. Neurosci. Bull., 2007, 23, 363-369.
123. Li, X.B.; Guan, Y.Q.; Ren, P.; Zhu, W.W.; Wang, Y.; Chan, P.; Ding, X.S.; Zhang, Y.A. The tropism of embryoid body cells for glioma cells. Neuroreport, 2007, 18, 1821-1825.
124. Liu, J.M.; Mao, B.Y.; Hong, S, Liu, Y.H, Wang, X.J. The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence. Adv. Ther., 2008, 25, 389-398.
125. Tang, C.; Ang, B.T.; Pervaiz, S. Cancer stem cell: Target for anticancer therapy. FASEB J., 2007, 21, 3777-3785.
126. Sauvageot, C.M.; Kesari, S, Stiles, C.D. Molecular Pathogenesis of Adult Brain Tumors and the Role of Stem Cells. Neurol. Clin., 2007, 25, 891-924.
127. Lee, da Y.; Gutmann, D.H. Cancer stem cells and brain tumors: Uprooting the bad seeds. Expert Rev. Anticancer Ther., 2007, 7, 1581-1590.
128. Rajan, P.; Srinivasan, R. Targeting cancer stem cells in cancer prevention and therapy. Stem Cell Rev., 2008, 4, 211-216.
129. Rubin, L.L. Stem cells and drug discovery: The beginning of a new era? Cell, 2008, 132, 549-552.
130. Zhao, R.C.; Zhu, Y.S.; Shi, Y. New hope for cancer treatment: Exploring the distinction between normal adult stem cells and cancer stem cells. Pharmacol. Ther., 2008, 119, 74-82.
131. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D.L.; Black, K.L.; Yu, J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 2004, 23, 9392-9400.
132. Chojnacki, A.; Weiss, S. Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat. Protoc., 2008, 3, 935-940.
133. Khaitan, D.; Chandna, S, Arya, M.B.; Dwarakanath, BS. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line. Cancer Biol. Ther., 2006, 5, 1142-1151.
134. Marshall, G.P 2nd.; Reynolds, B.A.; Laywell, E.D. Using the neurosphere assay to quantify neural stem cells in vivo. Curr. Pharm. Biotechnol., 2007, 8, 141-145.
135. Inagaki, A.; Soeda, A.; Oka, N.; Kitajima, H.; Nakagawa, J.; Motohashi, T.; Kunisada, T.; Iwama, T. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem. Biophys. Res. Commun., 2007, 361, 586-592.
136. Conti, L.; Pollard, S.M.; Gorba, T.; Reitano, E.; Toselli, M.; Biella, G.; Sun, Y.; Sanzone, S.; Ying, Q.L.; Cattaneo, E.; Smith, A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol., 2005, 3, e283.
137. Pollard, S.M.; Conti, L.; Sun, Y.; Goffre do, D.; Smith, A. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb. Cortex., 2006, 16 (Suppl 1), i112-120.
138. Glaser, T.; Pollard, S.M.; Smith, A.; Brustle, O. Tripotential differentiation of adherently expandable neural stem (NS) cells. PLoS ONE, 2007, 2, e298.
139. Conti, L.; Cattaneo, E.; Papadimou, E. Novel neural stem cell systems. Expert.Opin. Biol. Ther., 2008, 8, 153-160.
140. Sun, Y.; Pollard, S.; Conti, L.; Toselli, M.; Biella, G.; Parkin, G.; Willatt, L.; Falk, A.; Cattaneo, E.; Smith, A. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol. Cell Neurosci., 2008, 38, 245-258
141. Singh, S.K.; Clarke, I.D.; Hide, T.; Dirks, P.B. Cancer stem cell in nervous system tumors. Oncogene, 2004, 23, 7267-7273.
142. Wu, A.; Oh, S.; Wiesner, S.M.; Ericson, K.; Chen, L.; Hall, W.A.; Champoux, P.E.; Low, W.C.; Ohlfest, J.R. Persistence of CD133(+) cells in human and mouse glioma cell lines: Detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Dev., 2008, 17, 173-184.
143. Shu, Q.; Wong, K.K.; Su, J.M.; Adesina, A.M.; Yu, L.T.; Tsang, Y.T.; Antalffy, B.C.; Baxter, P.; Perlaky, L.; Yang, J.H.; Dauser, R.C.; Chintagumpala, M.; Blaney, S.M.; Lau, C.C.; Li, X.N. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells, 2008, 26, 1414-1424.
144. Shen, G.; Shen, F.; Shi, Z.; Liu, W.; Hu, W.; Zheng, X.; Wen, L.; Yang,. X. Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods. In Vitro Cell Dev. Biol. Anim., 2008, 44, 280-289.
145. Beier, D.; Hau, P.; Proescholdt, M.; Lohmeier, A.; Wischhusen, J.; Oefner, P.J.; Aigner, L.; Brawanski, A.; Bogdahn, U.; Beier, C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res., 2007, 67, 4010-4015.
146. Gunther, H.S.; Schmidt, N.O.; Phillips, H.S.; Kemming, D.; Kharbanda, S.; Soriano, R.; Modrusan, Z.; Meissner, H.; Westphal, M.; Lamszus, K. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene, 2008, 27, 2897-2909.
147. Bidlingmaier, S.; Zhu, X, Liu, B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J. Mol. Med., 2008, 86, 1025-1032.
148. Joo, K.M.; Kim, S.Y.; Jin, X.; Song, S.Y.; Kong, D.S.; Lee, J.I.; Jeon, J.W.; Kim, M.H.; Kang, B.G.; Jung, Y.; Jin, J.; Hong, S.C.; Park, W.Y.; Lee, D.S.; Kim, H.; Nam, D.H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest., 2008, 88, 808-815.
149. Yao, Y.; Wang, X.; Jin, K.; Zhu, J, Wang, Y.; Xiong, S.; Mao, Y, Zhou, L. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells. J. Neurooncol., 2008, 89, 121-129.
150. Kang, M.K.; Kang, S.K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev., 2007, 16, 837-848.
151. Kang, M.K.; Her, B.I.; Ko, M.H.; Kim, C.H.; Cha, S.H.; Kang, S.K. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci., 2008, 9, 15.
152. Ogden, A.T.; Waziri, A.E.; Lochhead, R.A.; Fusco, D.; Lopez, K.; Ellis, J.A.; Kang, J.; Assanah, M.; McKhann, G.M.; Sisti, M.B.; McCormick, P.C.; Canoll, P.; Bruce, J.N. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery, 2008, 62, 505-514.
153. De Filippis, L.; Lamorte, G.; Snyder, E.Y.; Malgaroli, A.; Vescovi, A.L. A novel, immortal and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells, 2007, 25, 2312-2321.
154. Lin, D.; Najbauer, J.; Salvaterra, P.M.; Mamelak, A.N.; Barish, M.E.; Garcia, E.; Metz, M.Z.; Kendall, S.E.; Bowers, M.; Kateb, B.; Kim, S.U.; Johnson, M.; Aboody, K.S. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. Neuroimage, 2007, 37 (Suppl 1), S18-26.
155. Manganas, L.N.; Zhang, X.; Li, Y.; Hazel, R.D.; Smith, S.D.; Wagshul, M.E.; Henn, F.; Benveniste, H.; Djuric, P.M.; Enikolopov, G.; Maletic-Savatic, M. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science, 2007, 318, 980-985.
156. Stupp, R.; Hegi, M.E.; Gilbert, M.R.; Chakravarti A. Chemoradiotherapy in malignant glioma: Standard of care and future directions. J. Clin. Oncol., 2007, 25, 4127-4136.
157. Hart, L.S.; El-Deiry, W.S. Invincible, but not invisible: Imaging approaches toward in vivo detection of cancer stem cells. J. Clin. Oncol., 2008, 26, 2901-2910.
158. Bao, S.; Wu, Q.; McLendon, R.E.; Hao, Y.; Shi, Q.; Hjelmeland, A.B.; Dewhirst, M.W.; Bigner, D.D.; Rich, J.N. Gliom stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 2006, 444, 756-760.
159. Rich, J.N. Cancer stem cells in radiation resistance. Cancer Res., 2007, 67, 8980-8984.
160. Kato, T.; Kanemura, Y.; Shiraishi, K.; Miyake, J.; Kodama, S.; Hara, M. Early response of neural stem/progenitor cells after X-ray irradiation in vitro. Neuroreport, 2007, 18, 895-900.
161. Eramo, A.; Ricci-Vitiani, L.; Zeuner, A.; Pallini, R.; Lotti, F.; Sette, G.; Pilozzi, E.; Larocca, L.M.; Peschle, C.; De Maria, R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ., 2006, 13, 1238-1241.
162. Beier, D.; Röhrl, S.; Pillai, D.R.; Schwarz, S.; Kunz-Schughart, L.A.; Leukel, P.; Proescholdt, M.; Brawanski, A.; Bogdahn, U.; Trampe-Kieslich, A.; Giebel, B.; Wischhusen, J.; Reifenberger, G.; Hau, P.; Beier, C.P. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res., 2008, 68, 5706-5715
163. Murat, A.; Migliavacca, E.; Gorlia, T.; Lambiv, W.L.; Shay, T.; Hamou, M.F.; de Tribolet, N.; Regli, L.; Wick, W.; Kouwenhoven, M.C.; Hainfellner, J.A.; Heppner, F.L.; Dietrich, P.Y.; Zimmer, Y.; Cairncross, J.G.; Janzer, R.C.; Domany, E.; Delorenzi, M.; Stupp, R.; Hegi, M.E. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J. Clin. Oncol., 2008, 26, 3015-3024.
164. Salmaggi, A.; Boiardi, A.; Gelati, M.; Russo, A.; Calatozzolo, C.; Ciusani, E.; Sciacca, F.L.; Ottolina, A.; Parati, E.A.; La Porta, C.; Alessandri, G.; Marras, C.; Croci, D.; De Rossi, M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia, 2006, 54, 850-860.
165. Jin, F.; Zhao, L.; Zhao, H.Y.; Guo, S.G.; Feng, J, Jiang, X.B.; Zhang, S.L.; Wei, Y.J.; Fu, R.; Zhao, J.S. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes. Neuroscience, 2008, 154, 541-550.
166. Tagscherer, K.E.; Fassl, A.; Campos, B.; Farhadi, M.; Kraemer, A.; Böck, B.C.; Macher-Goeppinger, S.; Radlwimmer, B.; Wiestler, O.D.; Herold-Mende, C.; Roth,W. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Oncogene, 2008, 27, 6646-6656.
167. Mammolenti, M.; Gajavelli, S.; Tsoulfas, P.; Levy, R. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells, 2004, 22, 1101-1110.
168. Hori, J.; Ng, T.F.; Shatos, M.; Klassen, H.; Streilein, J.W.; Young, M.J. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Ocul. Immunol. Inflamm., 2007, 15, 261-273.
169. Piccirillo, S.G.; Reynolds, B.A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi A.L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature, 2006, 444, 761-765.
170. Lee, J.; Son, M.J.; Woolard, K.; Donin, N.M.; Li, A.; Cheng, C.H.; Kotliarova, S.; Kotliarov, Y.; Walling, J.; Ahn, S.; Kim, M.; Totonchy, M.; Cusack, T.; Ene, C.; Ma, H.; Su, Q.; Zenklusen, J.C.; Zhang, W.; Maric, D.; Fine, H.A. Epigenetic-mediated dysfunction of the bone
171. Zhang, X.P.; Zheng, G.; Zou, L.; Liu, H.L.; Hou, L.H.; Zhou, P.; Yin, D.D.; Zheng, Q.J.; Liang, L.; Zhang, S.Z.; Feng, L.; Yao, L.B.; Yang, A.G.; Han, H.; Chen, J.Y. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol. Cell Biochem., 2008, 307, 101-108.
172. Fan, X.; Matsui, W.; Khaki, L.; Stearns, D.; Chun, J.; Li, Y.M.; Eberhart, C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res., 2006, 66, 7445-7452.
173. Soeda, A.; Inagaki, A.; Oka, N.; Ikegame, Y.; Aoki, H.; Yoshimura, S.I.; Nakashima, S.; Kunisada, T.; Iwama, T. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J. Biol. Chem., 2008, 283, 10958-10966.
174. Kao, G.D.; Jiang, Z.; Fernandes, A.M.; Gupta, A.K.; Maity, A. Inhibition of phosphatidylinositol-3-OH kinase/AKT signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J. Biol. Chem., 2007, 282, 21206-21212.
175. Kwon, C.H.; Zhao, D.; Chen, J.; Alcantara, S.; Li, Y.; Burns, D.K.; Mason, R.P.; Lee, E.Y.; Wu, H.; Parada, L.F. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res., 2008, 68, 3286-3294.
176. Aguado, T.; Carracedo, A.; Julien, B.; Velasco, G.; Milman, G.; Mechoulam, R.; Álvarez, L.; Guzman, M.; Galve-Roperh, I. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J. Biol. Chem., 2007, 282, 6854-6862.
177. Gilg, A.G.; Tye, S.L.; Tolliver, L.B.; Wheeler, W.G.; Visconti, R.P.; Duncan, J.D.; Kostova, F.V.; Bolds, L.N.; Toole, B.P.; Maria, B.L. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin. Cancer Res., 2008, 14, 1804-1813.
178. Toole, B.P.; Slomiany, M.G. Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells. Semin. Cancer Biol., 2008, 18, 244-250.
179. Silber, J.; Lim, D.A.; Petritsch, C.; Persson, A.I.; Maunakea, A.K.; Yu, M.; Vandenberg, S.R.; Ginzinger, D.G.; James, C.D.; Costello, J.F.; Bergers, G.; Weiss, W.A.; Alvarez-Buylla, A.; Hodgson, J.G. miR-124 and miR-137 inhibit proliferation of GBM cells and induce differentiation of brain tumor stem cells. BMC Med., 2008, 6, 14.
180. Kang, M.K.; Kang, S.K. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells. Biochem. Biophys. Res. Commun., 2008, 373, 539-544.
181. Ribacka, C.; Pesonen, S.; Hemminki, A. Cancer, stem cells, and oncolytic viruses. Ann. Med. 2008, 40, 496-505.
182. Nandi, S.; Ulasov, I.V.; Tyler, M.A.; Sugihara, A.Q.; Molinero, L.; Han, Y.; Zhu, Z.B.; Lesniak, M.S. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells. Cancer Res., 2008, 68, 5778-5784.
183. Bao, S.; Wu, Q.; Li, Z.; Sathornsumetee, S.; Wang, H.; McLendon, R.E.; Hjelmeland, A.B.; Rich, J.N. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res., 2008, 68, 6043-6048.
184. Shimato, S.; Natsume, A.; Takeuchi, H.; Wakabayashi, T.; Fujii, M.; Ito, M.; Ito, S.; Park, I.H.; Bang, J.H.; Kim, S.U.; Yoshida, J. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther., 2007, 14, 1132-1142.
185. Germano, I.M.; Uzzaman, M.; Keller, G. Gene delivery by embryonic stem cells for malignant glioma therapy: Hype or hope? Cancer Biol. Ther., 2008, 7, 1341-7.
186. Lorico, A.; Mercapide, J.; Soloduschko, V.; Alexeyev, M.; Fodstad, O.; Rappa, G. Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma. Cancer Gene Ther., 2008, 15, 605-615.
187. Uzzaman, M.; Keller, G.; Germano, I.M. In vivo gene delivery by embryonic stem cell-derived astrocytes for malignant gliomas. Neuro Oncol., 2008, in press.